Renal epithelial traffic jams and one-way streets

Journal of the American Society of Nephrology

Volumn 15, Issue 6, 2004, Pages 1370-1381

  Devonald, Mark A J ^a   Karet, Fiona E ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; BARTTER SYNDROME; CYSTINOSIS; DENT DISEASE; DISTAL KIDNEY TUBULE ACIDOSIS; FAMILIAL JUVENILE HYPERURICEMIC NEPHROPATHY; GITELMAN SYNDROME; GOLGI COMPLEX; HUMAN; HYPEROXALURIA; KIDNEY DISEASE; KIDNEY EPITHELIUM; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE ACIDOSIS; LIDDLE SYNDROME; LOWE SYNDROME; MEDULLARY SPONGE KIDNEY; NEPHROGENIC DIABETES INSIPIDUS; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; ROUGH ENDOPLASMIC RETICULUM;

EID: 2542418074     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000123804.18566.69     Document Type: Review

References (112)

1. Swanton E, Bulleid NJ: Protein folding and translocation across the endoplasmic reticulum membrane. Mol Membr Biol 20: 99-104, 2003
2. Rutishauser J, Spiess M: Endoplasmic reticulum storage diseases. Swiss Med Wkly 132: 211-222, 2002
3. Turner JJ, Stacey JM, Harding B, Kotanko P, Lhotta K, Puig JG, Roberts I, Torres RJ, Thakker RV: UROMODULIN mutations cause familial juvenile hyperuricemic nephropathy. J Clin Endocrinol Metab 88: 1398-1401, 2003
4. Bleyer AJ, Woodard AS, Shihabi Z, Sandhu J, Zhu H, Satko SG, Weller N, Deterding E, McBride D, Gorry MC, Xu L, Ganier D, Hart TC: Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene. Kidney Int 64: 36-42, 2003
5. Rampoldi L, Caridi G, Santon D, Boaretto F, Bernascone I, Lamorte G, Tardanico R, Dagnino M, Colussi G, Scolari F, Ghiggeri GM, Amoroso A, Casari G: Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. Hum Mol Genet 12: 3369-3384, 2003
6. Dahan K, Devuyst O, Smaers M, Vertommen D, Loute G, Poux JM, Viron B, Jacquot C, Gagnadoux MF, Chauveau D, Buchler M, Cochat P, Cosyns JP, Mougenot B, Rider MH, Antignac C, Verellen-Dumoulin C, Pirson Y: A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol 14: 2883-2893, 2003
7. Hayama A, Rai T, Sasaki S, Uchida S: Molecular mechanisms of Bartter syndrome caused by mutations in the BSND gene. Histochem Cell Biol 119: 485-493, 2003
8. Kunchaparty S, Palcso M, Berkman J, Velazquez H, Desir GV, Bernstein P, Reilly RF, Ellison DH: Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome. Am J Physiol 277: F643-F649, 1999
9. De Jong JC, Van Der Vliet WA, Van Den Heuvel LP, Willems PH, Knoers NV, Bindels RJ: Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome. J Am Soc Nephrol 13: 1442-1448, 2002
10. Oksche A, Rosenthal W: The molecular basis of nephrogenic diabetes insipidus. J Mol Med 76: 326-337, 1998
11. Marr N, Bichet DG, Hoefs S, Savelkoul PJ, Konings IB, De Mattia F, Graat MP, Arthus MF, Lonergan M, Fujiwara TM, Knoers NV, Landau D, Balfe WJ, Oksche A, Rosenthal W, Muller D, Van Os CH, Deen PM: Cell-biologic and functional analyses of five new Aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus, J Am Soc Nephrol 13: 2267-2277, 2002
12. Suchy SF, Olivos-Glander IM, Nussabaum RL: Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus. Hum Mol Genet 4: 2245-2250, 1995
13. De Camilli P, Emr SD, McPherson PS, Novick P: Phosphoinositides as regulators in membrane traffic, Science 271: 1533-1539, 1996
14. Faucherre A, Desbois P, Satre V, Lunardi J, Dorseuil O, Gacon G: Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network. Hum Mol Genet 12: 2449-2456, 2003
15. Duman JG, Forte JG: What is the role of SNARE proteins in membrane fusion? Am J Physiol Cell Physiol 285: C237-249, 2003
16. Bonifacino JS, Traub LM: Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 72: 395-447, 2003
17. Folsch H, Pypaert M, Schu P, Mellman I: Distribution and function of AP-1 clathrin adaptor complexes in polarized epithelial cells. J Cell Biol 152: 595-606, 2001
18. Folsch H, Ohno H, Bonifacino JS, Mellman I: A novel clathrin adaptor complex mediates basolateral targeting in polarized epithelial cells. Cell 99: 189-198, 1999
19. Mostov K, ter Beest MB, Chapin SJ: Catch the mu1B train to the basolateral surface. Cell 99: 121-122, 1999
20. Simmen T, Honing S, Icking A, Tikkanen R, Hunziker W: AP-4 binds basolateral signals and participates in basolateral sorting in epithelial MDCK cells. Nat Cell Biol 4: 154-159, 2002
21. Owen DJ, Luzio JP: Structural insights into clathrin-mediated endocytosis. Curr Opin Cell Biol 12: 467-474, 2000
22. Hirst J, Robinson MS: Clathrin and adaptors. Biochim Biophys Acta 1404: 173-193, 1998
23. Mostov KE: Regulation of protein traffic in polarized epithelial cells. Histol Histopathol 10: 423-431, 1995
24. Liddle G, Bledsoe T, Coppage W: A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Phys 76: 199-213, 1963
25. Botero-Velez M, Curtis JJ, Warnock DG: Brief report: Liddle's syndrome revisited-A disorder of sodium reabsorption in the distal tubule. N Engl J Med 330: 178-181, 1994
26. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW, et al: Liddle's syndrome: Heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79: 407-414, 1994
27. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP: Hypertension caused by a truncated epithelial sodium channel gamma subunit: Genetic heterogeneity of Liddle syndrome. Nat Genet 11: 76-82, 1995
28. Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger JD, Rossier BC: Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature 367: 463-467, 1994
29. Rossier BC, Pradervand S, Schild L, Hummler E: Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors. Annu Rev Physiol 64: 877-897, 2002
30. Eskandari S, Snyder PM, Kreman M, Zampighi GA, Welsh MJ, Wright EM: Number of subunits comprising the epithelial sodium channel. J Biol Chem 274: 27281-27286, 1999
31. Snyder PM, Cheng C, Prince LS, Rogers JC, Welsh MJ: Electrophysiological and biochemical evidence that DEG/ENaC cation channels are composed of nine subunits. J Biol Chem 273: 681-684, 1998
32. Staub O, Gautschi I, Ishikawa T, Breitschopf K, Ciechanover A, Schild L, Rotin D: Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination. EMBO J 16: 6325-6336, 1997
33. Gormley K, Dong Y, Sagnella GA: Regulation of the epithelial sodium channel by accessory proteins. Biochem J 371: 1-14, 2003
34. Garty H, Palmer LG: Epithelial sodium channels: function, structure, and regulation. Physiol Rev 77: 359-396, 1997
35. Shimkets RA, Lifton R, Canessa CM: In vivo phosphorylation of the epithelial sodium channel. Proc Natl Acad Sci U S A 95: 3301-3305, 1998
36. + channels. J Biol Chem 274: 16973-16978, 1999
37. Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, Pearce D: Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci U S A 96: 2514-2519, 1999
38. Hansson JH, Schild L, Lu Y, Wilson TA, Gautschi I, Shimkets R, Nelson-Williams C, Rossier BC, Lifton RP: A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci U S A 92: 11495-11499, 1995
39. Snyder PM: Liddle's syndrome mutations disrupt cAMP-mediated translocation of the epithelial Na(+) channel to the cell surface. J Clin Invest 105: 45-53, 2000
40. Staub O, Dho S, Henry P, Correa J, Ishikawa T, McGlade J, Rotin D: WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome. EMBO J 15: 2371-2380, 1996
41. Kanelis V, Rotin D, Forman-Kay JD: Solution structure of a Nedd4 WW domain-ENaC peptide complex. Nat Struct Biol 8: 407-412, 2001
42. Lott JS, Coddington-Lawson SJ, Teesdale-Spittle PH, McDonald FJ: A single WW domain is the predominant mediator of the interaction between the human ubiquitin-protein ligase Nedd4 and the human epithelial sodium channel. Biochem J 361: 481-488, 2002
43. Snyder PM, Steines JC, Olson DR: Relative contribution of Nedd4 and Nedd4-2 to ENaC regulation in epithelia determined by RNA interference. J Biol Chem 279: 5042-5046, 2003
44. McDonald FJ, Western AH, McNeil JD, Thomas BC, Olson DR, Snyder PM: Ubiquitin-protein ligase WWP2 binds to and downregulates the epithelial Na(+) channel. Am J Physiol Renal Physiol 283: F431-F436, 2002
45. Malbert-Colas L, Nicolas G, Galand C, Lecomte MC, Dhermy D: Identification of new partners of the epithelial sodium channel alpha subunit. C R Biol 326: 615-624, 2003
46. Staub O, Abriel H, Plant P, Ishikawa T, Kanelis V, Saleki R, Horisberger JD, Schild L, Rotin D: Regulation of the epithelial Na+ channel by Nedd4 and ubiquitination. Kidney Int 57: 809-815, 2000
47. Pradervand S, Wang Q, Burnier M, Beermann F, Horisberger JD, Hummler E, Rossier BC: A mouse model for Liddle's syndrome. J Am Soc Nephrol 10: 2527-2533, 1999
48. Pradervand S, Vandewalle A, Bens M, Gautschi I, Loffing J, Hummler E, Schild L, Rossier BC: Dysfunction of the epithelial sodium channel expressed in the kidney of a mouse model for Liddle syndrome. J Am Soc Nephrol 14: 2219-2228, 2003
49. Dahlmann A, Pradervand S, Hummler E, Rossier BC, Frindt G, Palmer LG: Mineralocorticoid regulation of epithelial Na+ channels is maintained in a mouse model of Liddle's syndrome. Am J Physiol Renal Physiol 285: F310-F318, 2003
50. van Lieburg AF, Knoers NV, Monnens LA: Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 10: 1958-1964, 1999
51. Morello JP, Bichet DG: Nephrogenic diabetes insipidus. Annu Rev Physiol 63: 607-630, 2001
52. Wade JB, Stetson DL, Lewis SA: ADH action: evidence for a membrane shuttle mechanism. Ann N Y Acad Sci 372: 106-117, 1981
53. Nielsen S, Chou CL, Marples D, Christensen EI, Kishore BK, Knepper MA: Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A 92: 1013-1017, 1995
54. Katsura T, Gustafson CE, Ausiello DA, Brown D: Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PK1 cells. Am J Physiol 272: F817-F822, 1997
55. Brown D: The ins and outs of aquaporin-2 trafficking. Am J Physiol Renal Physiol 284: F893-F901, 2003
56. Gustafson CE, Katsura T, McKee M, Bouley R, Casanova JE, Brown D: Recycling of AQP2 occurs through a temperature- and bafilomycin-sensitive trans-Golgi-associated compartment. Am J Physiol Renal Physiol 278: F317-F326, 2000
57. Lu H, Sun TX, Bouley R, Blackburn K, McLaughlin M, Brown D: Inhibition of endocytosis causes phosphorylation (S256)-independent plasma membrane accumulation of AQP-2. Am J Physiol Renal Physiol 286: F233-F243, 2003
58. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, Birnbaumer M, Bichet DG: Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359: 233-235, 1992
59. van den Ouweland AM, Dreesen JC, Verdijk M, Knoers NV, Monnens LA, Rocchi M, van Oost BA: Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet 2: 99-102, 1992
60. Holtzman EJ, Kolakowski LF, Jr., O'Brien D, Crawford JD, Ausiello DA: A Null mutation in the vasopressin V2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus in the Hopewell kindred. Hum Mol Genet 2: 1201-1204, 1993
61. Morello JP, Salahpour A, Laperriere A, Bernier V, Arthus MF, Lonergan M, Petaja-Repo U, Angers S, Morin D, Bichet DG, Bouvier M: Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest 105: 887-895, 2000
62. Tan CM, Nickols HH, Limbird LE: Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation. J Biol Chem 278: 35678-35686, 2003
63. Deen PM, Croes H, van Aubel RA, Ginsel LA, van Os CH: Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest 95: 2291-2296, 1995
64. Mulders SM, Knoers NV, Van Lieburg AF, Monnens LA, Leumann E, Wuhl E, Schober E, Rijss JP, Van Os CH, Deen PM: New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol 8: 242-248, 1997
65. Kamsteeg EJ, Wormhoudt TA, Rijss JP, van Os CH, Deen PM: An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J 18: 2394-2400, 1999
66. Marr N, Bichet DG, Lonergan M, Arthus MF, Jeck N, Seyberth HW, Rosenthal W, van Os CH, Oksche A, Deen PM: Heteroligomerization of an Aquaporin-2 mutant with wild-type Aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus. Hum Mol Genet 11: 779-789, 2002
67. Mulders SM, Bichet DG, Rijss JP, Kamsteeg EJ, Arthus MF, Lonergan M, Fujiwara M, Morgan K, Leijendekker R, van der Sluijs P, van Os CH, Deen PM: An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest 102: 57-66, 1998
68. Kuwahara M, Iwai K, Ooeda T, Igarashi T, Ogawa E, Katsushima Y, Shinbo I, Uchida S, Terada Y, Arthus MF, Lonergan M, Fujiwara TM, Bichet DG, Marumo F, Sasaki S: Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus. Am J Hum Genet 69: 738-748, 2001
69. Kamsteeg EJ, Bichet DG, Konings IB, Nivet H, Lonergan M, Arthus MF, Van Os CH, Deen PM: Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidus. J Cell Biol 163: 1099-1109, 2003
70. Van Balkom BW, Graat MP, Van Raak M, Hofman E, Van Der Sluijs P, Deen PM: Role of the cytoplasmic termini in the sorting and shuttling of the Aquaporin-2 water channel. Am J Physiol Cell Physiol 286: C372-C379, 2004
71. Wrong OM, Feest TG, MacIver AG: Immune-related potassium-losing interstitial nephritis: A comparison with distal renal tubular acidosis. Q J Med 86: 513-534, 1993
72. Karet FE: Inherited distal renal tubular acidosis. J Am Soc Nephrol 13: 2178-2184, 2002
73. Batlle D, Ghanekar H, Jain S, Mitra A: Hereditary distal renal tubular acidosis: New understandings. Annu Rev Med 52: 471-484, 2001
74. Bruce LJ, Cope DL, Jones GK, Schofield AE, Burley M, Povey S, Unwin RJ, Wrong O, Tanner MJ: Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest 100: 1693-1707, 1997
75. Jarolim P, Shayakul C, Prabakaran D, Jiang L, Stuart-Tilley A, Rubin HL, Simova S, Zavadil J, Herrin JT, Brouillette J, Somers MJ, Seemanova E, Brugnara C, Guay-Woodford LM, Alper SL: Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl-/HCO3-exchanger. J Biol Chem 273: 6380-6388, 1998
76. Karet FE, Gainza FJ, Gyory AZ, Unwin RJ, Wrong O, Tanner MJ, Nayir A, Alpay H, Santos F, Hulton SA, Bakkaloglu A, Ozen S, Cunningham MJ, di Pietro A, Walker WG, Lifton RP: Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A 95: 6337-6342, 1998
77. Weber S, Soergel M, Jeck N, Konrad M: Atypical distal renal tubular acidosis confirmed by mutation analysis. Pediatr Nephrol 15: 201-204, 2000
78. Sritippayawan S, Kirdpon S, Vasuvattakul S, Wasanawatana S, Susaengrat W, Waiyawuth W, Nimmannit S, Malasit P, Yenchitsomanus PT: A de novo R589C mutation of anion exchanger 1 causing distal renal tubular acidosis. Pediatr Nephrol 18: 644-648, 2003
79. Jarolim P, Murray JL, Rubin HL, Taylor WM, Prchal JT, Ballas SK, Snyder LM, Chrobak L, Melrose WD, Brabec V, Palek J: Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood 88: 4366-4374, 1996
80. Toye AM, Bruce LJ, Unwin RJ, Wrong O, Tanner MJ: Band 3 Walton, a C-terminal deletion associated with distal renal tubular acidosis, is expressed in the red cell membrane but retained internally in kidney cells. Blood 99: 342-347, 2002
81. Quilty JA, Li J, Reithmeier RA: Impaired trafficking of distal renal tubular acidosis mutants of the human kidney anion exchanger kAE1. Am J Physiol Renal Physiol 282: F810-F820, 2002
82. Quilty JA, Cordat E, Reithmeier RA: Impaired trafficking of human kidney anion exchanger (kAE1) caused by hetero-oligomer formation with a truncated mutant associated with distal renal tubular acidosis. Biochem J 368: 895-903, 2002
83. Devonald MA, Smith AN, Poon JP, Ihrke G, Karet FE: Non-polarized targeting of AE1 causes autosomal dominant distal renal tubular acidosis. Nat Genet 33: 125-127, 2003
84. Kalatzis V, Antignac C: New aspects of the pathogenesis of cystinosis. Pediatr Nephrol 18: 207-215, 2003
85. Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD: Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 217: 1263-1265, 1982
86. Steinherz R, Tietze F, Gahl WA, Triche TJ, Chiang H, Modesti A, Schulman JD: Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci U S A 79: 4446-4450, 1982
87. Pellett OL, Smith ML, Greene AA, Schneider JA: Lack of complementation in somatic cell hybrids between fibroblasts from patients with different forms of cystinosis. Proc Natl Acad Sci U S A 85: 3531-3534, 1988
88. Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, van't Hoff W, Antignac C: A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 18: 319-324, 1998
89. Cherqui S, Kalatzis V, Trugnan G, Antignac C: The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif. J Biol Chem 276: 13314-13321, 2001
90. Haq MR, Kalatzis V, Gubler MC, Town MM, Antignac C, Van't Hoff WG, Woolf AS: Immunolocalization of cystinosin, the protein defective in cystinosis. J Am Soc Nephrol 13: 2046-2051, 2002
91. Kalatzis V, Cherqui S, Antignac C, Gasnier B: Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J 20: 5940-5949, 2001
92. Shotelersuk V, Larson D, Anikster Y, McDowell G, Lemons R, Bernardini I, Guo J, Thoene J, Gahl WA: CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet 63: 1352-1362, 1998
93. Kalatzis V, Cohen-Solal L, Cordier B, Frishberg Y, Kemper M, Nuutinen EM, Legrand E, Cochat P, Antignac C: Identification of 14 novel CTNS mutations and characterization of seven splice site mutations associated with cystinosis. Hum Mutat 20: 439-446, 2002
94. Fisher SE, Black GC, Lloyd SE, Hatchwell E, Wrong O, Thakker RV, Craig IW: Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candidate for Dent's disease (an X-linked hereditary nephrolithiasis). Hum Mol Genet 3: 2053-2059, 1994
95. Frymoyer PA, Scheinman SJ, Dunham PB, Jones DB, Hueber P, Schroeder ET: X-linked recessive nephrolithiasis with renal failure. N Engl J Med 325: 681-686, 1991
96. Bolino A, Devoto M, Enia G, Zoccali C, Weissenbach J, Romeo G: Genetic mapping in the Xp11.2 region of a new form of X-linked hypophosphatemic rickets. Eur J Hum Genet 1: 269-279, 1993
97. Lloyd SE, Gunther W, Pearce SH, Thomson A, Bianchi ML, Bosio M, Craig IW, Fisher SE, Scheinman SJ, Wrong O, Jentsch TJ, Thakker RV: Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders. Hum Mol Genet 6: 1233-1239, 1997
98. Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW, Thakker RV: A common molecular basis for three inherited kidney stone diseases. Nature 379: 445-449, 1996
99. Devuyst O, Christie PT, Courtoy PJ, Beauwens R, Thakker RV: Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. Hum Mol Genet 8: 247-257, 1999
100. Gunther W, Luchow A, Cluzeaud F, Vandewalle A, Jentsch TJ: ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci U S A 95: 8075-8080, 1998
101. Schwake M, Friedrich T, Jentsch TJ: An internalization signal in ClC-5, an endosomal Cl-channel mutated in dent's disease. J Biol Chem 276: 12049-12054, 2001
102. Yamamoto K, Cox JP, Friedrich T, Christie PT, Bald M, Houtman PN, Lapsley MJ, Patzer L, Tsimaratos M, Van THWG, Yamaoka K, Jentsch TJ, Thakker RV: Characterization of renal chloride channel (CLCN5) mutations in Dent's disease. J Am Soc Nephrol 11: 1460-1468, 2000
103. Piwon N, Gunther W, Schwake M, Bosl MR, Jentsch TJ: ClC-5 Cl-channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408: 369-373, 2000
104. Marshansky V, Ausiello DA, Brown D: Physiological importance of endosomal acidification: potential role in proximal tubulopathies. Curr Opin Nephrol Hypertens 11: 527-537, 2002
105. Christensen EI, Devuyst O, Dom G, Nielsen R, Van der Smissen P, Verroust P, Leruth M, Guggino WB, Courtoy PJ: Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci U S A 100: 8472-8477, 2003
106. Gunther W, Piwon N, Jentsch TJ: The ClC-5 chloride channel knock-out mouse-An animal model for Dent's disease. Pflugers Arch 445: 456-462, 2003
107. Carr G, Simmons N, Sayer J: A role for CBS domain 2 in trafficking of chloride channel CLC-5. Biochem Biophys Res Commun 310: 600-605, 2003
108. Leumann E, Hoppe B: The primary hyperoxalurias. J Am Soc Nephrol 12: 1986-1993, 2001
109. Watts RW, Calne RY, Rolles K, Danpure CJ, Morgan SH, Mansell MA, Williams R, Purkiss P: Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet 2: 474-475, 1987
110. Leiper JM, Danpure CJ: A unique molecular basis for enzyme mistargeting in primary hyperoxaluria type 1. Clin Chim Acta 266: 39-50, 1997
111. Danpure CJ, Lumb MJ, Birdsey GM, Zhang X: Alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting in human hereditary kidney stone disease. Biochim Biophys Acta 1647: 70-75, 2003
112. Sutters M, Germino GG: Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J Lab Clin Med 141: 91-101, 2003